Immunochemistry: A small non-immunogenic molecule can elicit an immune response after covalent conjugation to which type of macromolecule?

Difficulty: Easy

Correct Answer: Carrier

Explanation:


Introduction:
Small molecules (haptens) are generally not immunogenic on their own. However, when covalently linked to a large, immunogenic macromolecule, they can induce specific antibody responses. This question asks you to identify the macromolecule that provides immunogenicity upon conjugation.


Given Data / Assumptions:

  • Haptens are small and non-immunogenic without a protein scaffold.
  • Conjugation presents the hapten in a multivalent, T-cell-help-competent context.
  • Protein carriers supply T-cell epitopes required for help-dependent antibody responses.


Concept / Approach:
The correct term for the macromolecule that confers immunogenicity is the carrier. The hapten is the small molecule; the adjuvant is a formulation component that enhances responses but is not the covalently linked scaffold; mitogens and superantigens activate many lymphocytes nonspecifically and are unrelated to hapten-carrier conjugation.


Step-by-Step Solution:

Define hapten: small, non-immunogenic antigenic determinant.Identify carrier: immunogenic protein that provides T-cell epitopes.Mechanism: conjugation enables processing/presentation → T-cell help → anti-hapten antibodies.Conclusion: the macromolecule is the carrier.


Verification / Alternative check:
Classical experiments (e.g., dinitrophenyl conjugated to keyhole limpet hemocyanin) demonstrate robust anti-hapten responses only when a protein carrier is present.


Why Other Options Are Wrong:

  • Adjuvant: boosts immunity but is not the covalent scaffold.
  • Hapten: the small molecule itself, not the macromolecular partner.
  • Mitogen/superantigen: cause polyclonal activation, not specific hapten responses.


Common Pitfalls:
Confusing the terms hapten and carrier or assuming adjuvants must be covalently attached.


Final Answer:
Carrier

Discussion & Comments

No comments yet. Be the first to comment!
Join Discussion